Member Info for chrishutch

Price should be a lot higher

Re posting cause a few haven’t researched this at all.

Looking at the #fab sp it feels like a boxer on the ropes, but that is a reflection of last year

Fundamentally @FsnAntibodies are turning things around. They are just not very good at telling the market about it.

🙈long cash runway

🙈expect to reach profitability with existing funds

🙈business pipeline 3 times stronger and that is across the board, all services

🙈increasing penetration of adjacent markets such as Veterinary Medicine, Diagnostics

🙈 a research collaboration is under discussion to trial OptiMAL® for cancer

🙈cutting edge world class services

🙈overheads drastically cut

🙈new partnerships won

🙈new op manger to meet demand

🙈government grants also on cards

🙈 Oxford and Cambridge Ai and medical researchers

🙈contracts under discussion.

🙈focus switching to accommodate both high level pharma and small companies

I think the company has a very good chance of a decent recovery, there are very few shares in issue and so any one of the many pipeline catalysts could mean the price jumps considerably.

Looking at the #fab sp it feels like a boxer on the ropes, but that is a reflection of last year

Fundamentally @FsnAntibodies are turning things around. They are just not very good at telling the market about it.

🙈long cash runway

🙈expect to reach profitability with existing funds

🙈business pipeline 3 times stronger and that is across the board, all services

🙈increasing penetration of adjacent markets such as Veterinary Medicine, Diagnostics

🙈 a research collaboration is under discussion to trial OptiMAL® for cancer

🙈cutting edge world class services

🙈overheads drastically cut

🙈new partnerships won

🙈new op manger to meet demand

🙈government grants also on cards

🙈 Oxford and Cambridge Ai and medical researchers

🙈contracts under discussion.

🙈focus switching to accommodate both high level pharma and small companies

I think the company has a very good chance of a decent recovery, there are very few shares in issue and so any one of the many pipeline catalysts could mean the price jumps considerably.

For me

Maybe they will buy fab out with there new expansion monies.

https://www.almacgroup.com/news/almac-group-releases-details-of-80-million-expansion-in-northern-ireland/

Be interesting to see if we get partnership news next week, they seemed close to finalising it in recent interview.

Https://www.linkedin.com/posts/fusion-antibodies-plc_last-night-we-had-over-200-students-come-activity-7118531582994337792-3mMN?utm_source=share&utm_medium=member_ios

Https://www.linkedin.com/posts/fusion-antibodies-plc_challengeus-ai-antibodydiscovery-activity-7118150817643130880-aZ2G?utm_source=share&utm_medium=member_ios

:=)

Has to move at some point

Some say a 1 share code means an rns is lodged

Just went through

Https://youtu.be/uIk3eAmjcT0?si=sOp5AVr6tw5H17sJ

Next news will be positive, they pretty much told us business is improving, they have three fold pipeline across all services.

We just don’t know what comes first,

Partnership secured, new contracts signed, director buys, my hunch is new guy who has had a close look over the accounts will take a starter position as soon as not inside.

Also Adrian might buy some as the price is so cheap, it would be seen as a real positive, they would not be able to (currently) as they disclosed they are in discussions with new partner.

Nothing really in that rns, mate, just a formality, refers to the past and is just advising that despite options/security’s being available none were issued. Some lapsed, which makes sense considering they would be at a higher price than share price at the time

I thought the comment that they are increasing penetration of adjacent markets such as Veterinary Medicine, Diagnostics, Research antibodies was interesting but seemed to go unnoticed by most.

As well as using the mention that a research collaboration was under discussion to trial OptiMAL® for #cancer targets

Yeah off to chase rainbows no doubt.

Maybe when those that are unable to watch during the day see the presentation we will see more interest. Not sure why the price is still down here to be honest

I expected more retail interest, but clearly they are off chasing much worse opportunities, I will sit it out and wait for a decent re-reate. That interview was confidence-inducing and I believe the company is at an inflection point.

Just a waiting for either the rest of retail to notice that this company is worth more than 2.2mcap or the company to drop a material rns. One or the other will happen.

:-)